Form 10-Q VERACYTE, INC. For: Mar 31

Go back to Form 10-Q VERACYTE, INC. For: Mar 31

Veracyte, Inc (VCYT) PT Lowered to $26 at Needham & Company

May 4, 2022 6:51 AM EDT

Needham & Company analyst Mike Matson lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $26.00 (from $31.00) while maintaining a Buy rating following earnings.

The analyst commented, "VCYT's 1Q22 revenue and EPS beat consensus. Organic revenue growth (excluding estimated revenue from Decipher and... More